TRPV1 and breast adenocarcinoma: The anti-breast cancer effect of tramadol appears to involve the inhibition of proliferation, induction of apoptosis, and effects on 5-HT2B receptor and TRPV-1 for Michigan Cancer Foundation-7 (MCF-7, breast adenocarcinoma cell) [7].